g8
2 楼
The first new treatment for lupus in a half-century won U.S. approval on
Wednesday, a milestone for patients with the disabling disease and a
potential blockbuster for tiny biotech company Human Genome Sciences.
Health officials cleared Benlysta for certain patients with active lupus who
are receiving standard therapy. The disease causes the immune system to
attack joints and organs and has proved tough to study and treat.
Human Genome will split profits from the drug with GlaxoSmithKline.
In clinical trials, black patients "did not appear to respond to treatment,"
the FDA said. To address that concern, the company will run another study
to further examine safety and effectiveness in black patients, the agency
said.
Benlysta's annual global sales may top $3 billion in 2015, according to
Thomson Reuters consensus forecasts.
Wednesday, a milestone for patients with the disabling disease and a
potential blockbuster for tiny biotech company Human Genome Sciences.
Health officials cleared Benlysta for certain patients with active lupus who
are receiving standard therapy. The disease causes the immune system to
attack joints and organs and has proved tough to study and treat.
Human Genome will split profits from the drug with GlaxoSmithKline.
In clinical trials, black patients "did not appear to respond to treatment,"
the FDA said. To address that concern, the company will run another study
to further examine safety and effectiveness in black patients, the agency
said.
Benlysta's annual global sales may top $3 billion in 2015, according to
Thomson Reuters consensus forecasts.
f*r
3 楼
我的也是,打了好几次电话,结果被踢来踢去,最后也没解决,只好到信用卡公司DISPUTE
了.
了.
相关阅读
我GRASS，盘后跌破112难道有什么消息露出来了？UAL要绿了现在还没有收到 broker 收紧margin 的通知。黑老大Wow, huge drop抄底结束！！！我日，TNA跌了25%了油油呢？赚死了还是亏残了？Optionhouse真扯淡明天又是崭新的一天美国将往何处去？ (转载)奥巴马: "Our problems are solvable" (转载)这辈子命好，三年两次大的，哥哥要继续发达了上周四的跌幅勉强挤进了前10，今天能进前5吗？That is quite a drop牛牛们回答一个问题，QE3能挽救这个跌势么？daytraders must love s&p to death弹起来了out for lunch, $7 budget...